Testing a phone app to deliver glioma treatment at home
Original title: A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is given for this study, so it is still being tested in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a mobile app that lets people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary get therapy at home and stay in touch with their care team.
Who this trial is for. This trial is for people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. It tests a digital treatment platform that uses a mobile app to deliver home-based sequential therapy. The app is meant to give patients steady contact with their care team while they are at home.
Where it stands. The trial has not reported results. It is measuring how well this app-based platform works for giving home-based sequential therapy to people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Many people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary live far from a center with neuro-oncology specialists. Others cannot travel because of disability or cost. This study is looking at whether care delivered through an app at home can help with that gap. Someone who fits the study might ask their care team about it.
What it doesn't mean: This does not mean the platform is proven to work. A trial is a test, not a treatment you can count on. Joining a trial is not a guarantee that you will be helped. This is not a cure, and it is not a promise of one. Only the trial team can decide who may take part.
Source: ClinicalTrials.gov, August 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.